Baystate Wealth Management’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
DTC
EAM
Baystate Wealth Management's GH Position: Q4 2023 in Review
Baystate Wealth Management sold out of Guardant Health (GH) in Q4 2023, closing a stake of 80 shares — an estimated $2.37K sold.
Baystate Wealth Management first reported a position in GH in Q3 2020 and held it in 4 quarters. The position peaked at $2.86K in Q2 2023. 294 funds tracked by Wall St. Rank hold GH as of Q4 2023.
- Baystate Wealth Management reported no remaining Guardant Health position as of Q4 2023 after selling out during the quarter.
- Baystate Wealth Management sold 80 Guardant Health shares in Q4 2023, an estimated $2.37K.
- Baystate Wealth Management first reported a position in Guardant Health in Q3 2020 and held it in 4 quarters.
- Baystate Wealth Management's Guardant Health position peaked at $2.86K in Q2 2023.
- 294 funds tracked by Wall St. Rank held Guardant Health as of Q4 2023.
Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.